Mind Medicine (MindMed) Inc. develops novel products to treat brain health disorders related to psychiatry,addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder.
